Filing Details
- Accession Number:
- 0001683168-23-008940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-18 19:31:12
- Reporting Period:
- 2023-12-14
- Accepted Time:
- 2023-12-18 19:31:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 704562 | Avid Bioservices Inc. | CDMO | Pharmaceutical Preparations (2834) | 953698422 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1723288 | B Richard Hancock | 14191 Myford Road Tustin CA 92780 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2023-12-14 | 9,612 | $0.00 | 55,760 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Acquisiton | 2023-12-15 | 23,000 | $5.86 | 78,760 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-12-14 | 9,612 | $0.00 | 9,612 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2023-12-14 | 26,756 | $0.00 | 26,756 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,014 | No | 4 | M | Direct | ||
| 33,770 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $5.825 to $5.90. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023.
- Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
- RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date.
Billionaire Hedge Funds
